U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07486752) titled 'BAG3-DCM Natural History Study' on March 12.
Brief Summary: The goal of this international observational study is to learn about the natural history of Dilated Cardiomyopathy (DCM) arising from pathogenic BAG3 variants in adult patients >=18 years of age.
Study Start Date: May, 2026
Study Type: OBSERVATIONAL
Condition:
Dilated Cardiomyopathy (DCM)
Cardiovascular Diseases
Heart Diseases
Genetic Diseases
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Rocket Pharmaceuticals Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....